Publication | Closed Access

Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo

Early TnbcTumor Mutational BurdenCancer ImmunosurveillanceMedicineImmunologyPathologyImmune InfiltrationImmune Checkpoint InhibitorCancer TreatmentImmunotherapyOncologyTumor Biology